Phage Display Services: Advancing Antibody Discovery & Protein Engineering

Phage display is a powerful biotechnology tool used for antibody discovery, protein engineering, and peptide screening. At KS-V Peptide, we provide high-quality phage display services to support research in therapeutics, diagnostics, and drug development.

What is Phage Display?

Phage display is a molecular biology technique where bacteriophages (viruses that infect bacteria) are engineered to express peptides or proteins on their surface. This allows researchers to:

Screen large libraries of antibodies, peptides, or proteins

Identify high-affinity binders for targets like receptors, antigens, or enzymes

Optimize protein interactions for therapeutic and diagnostic applications

Our Phage Display Services

We offer customized phage display solutions, including:

1. Antibody Phage Display

Construction of immune/non-immune antibody libraries (scFv, Fab, VHH)

Panning & selection against your target antigen

High-throughput screening for lead candidates

2. Peptide Phage Display

Random or focused peptide libraries for epitope mapping

Biopanning to identify bioactive peptides

Hit validation via ELISA, SPR, or cell-based assays

3. Protein Engineering & Optimization

Affinity maturation to enhance binding strength

Stability & solubility improvements for therapeutic proteins

Humanization of antibodies for clinical development

Why Choose KS-V Peptide?

✅ High-Diversity Libraries (>10^10 unique clones)

✅ Customized Solutions for your specific target

✅ Fast Turnaround with efficient screening

✅ End-to-End Support from library to leads

Applications

• Therapeutic antibody discovery

• Diagnostic biomarker detection

• Vaccine development

• Protein interaction studies

Partner With Us

Explore our phage display services to accelerate your research.

🔗 Connect with us: https://www.linkedin.com/company/ks-v-peptide/

longpeptide

KS-V Peptide has provided peptide services to over 1,000 academic clients and 100 industrial clients from more than 30 countries. We are committed to promoting innovation to support drug research and

0コメント

  • 1000 / 1000